123 related articles for article (PubMed ID: 28276595)
1. A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.
ShahidSales S; Mehramiz M; Ghasemi F; Aledavood A; Shamsi M; Hassanian SM; Ghayour-Mobarhan M; Avan A
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28276595
[TBL] [Abstract][Full Text] [Related]
2. Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.
Seifi S; Pouya F; Rahmani M; Mehramiz M; Rastgar-Moghadam A; Gharib M; Rahmani F; Shahidsales S; Hassanian SM; Khazaei M; Dadjoo P; Parvin SS; Yazdinezhad Y; Parizadeh SMR; Ferns GA; Fathi M; Avan A
J Cell Physiol; 2020 Jun; 235(6):5141-5145. PubMed ID: 31721206
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Ghobadi N; Mehramiz M; ShahidSales S; Rezaei Brojerdi A; Anvari K; Khazaei M; Rezayi M; Sadegh Khorrami M; Joudi-Mashhad M; Ramshini H; Ahmadi-Simab S; Moradi A; Hassanian SM; Ghayour-Mobarhan M; Boroushaki MT; Ferns GA; Avan A
J Cell Physiol; 2019 Apr; 234(4):5070-5076. PubMed ID: 30238987
[TBL] [Abstract][Full Text] [Related]
4. Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: A step toward personalized nutrition.
Mehramiz M; Ghasemi F; Esmaily H; Tayefi M; Hassanian SM; Sadeghzade M; Sadabadi F; Moohebati M; Azarpazhooh MR; Parizadeh SMR; Heidari-Bakavoli A; Safarian M; Nematy M; Ebrahimi M; Ryzhikov M; Ferns GA; Ghayour-Mobarhan M; Avan A
Clin Nutr; 2018 Feb; 37(1):254-261. PubMed ID: 28065479
[TBL] [Abstract][Full Text] [Related]
5. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.
Noury AE; Azmy O; Alsharnoubi J; Salama S; Okasha A; Gouda W
BMC Res Notes; 2018 Mar; 11(1):181. PubMed ID: 29544538
[TBL] [Abstract][Full Text] [Related]
6. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
[TBL] [Abstract][Full Text] [Related]
7. CDC123/CAMK1D gene rs12779790 polymorphism and rs10811661 polymorphism upstream of the CDKN2A/2B gene in women with gestational diabetes.
Tarnowski M; Malinowski D; Safranow K; Dziedziejko V; Pawlik A
J Perinatol; 2017 Apr; 37(4):345-348. PubMed ID: 28079868
[TBL] [Abstract][Full Text] [Related]
8. Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer.
Sardarzadeh N; Khojasteh-Leylakoohi F; Damavandi S; Khalili-Tanha G; Dashtiahangar M; Khalili-Tanha N; Avan A; Amoueian S; Hassanian SM; Esmaily H; Khazaei M; Ferns G; Khooei A; Aliakbarian M
Rep Biochem Mol Biol; 2022 Jul; 11(2):336-343. PubMed ID: 36164638
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
Beihaghi M; Sahebi R; Beihaghi MR; Nessiani RK; Yarasmi MR; Gholamalizadeh S; Shahabnavaie F; Shojaei M
BMC Cancer; 2023 Oct; 23(1):985. PubMed ID: 37845622
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men.
Akinyemi R; Arnett DK; Tiwari HK; Ovbiagele B; Sarfo F; Srinivasasainagendra V; Irvin MR; Adeoye A; Perry RT; Akpalu A; Jenkins C; Owolabi L; Obiako R; Wahab K; Sanya E; Komolafe M; Fawale M; Adebayo P; Osaigbovo G; Sunmonu T; Olowoyo P; Chukwuonye I; Obiabo Y; Akpa O; Melikam S; Saulson R; Kalaria R; Ogunniyi A; Owolabi M;
J Neurol Sci; 2017 Aug; 379():229-235. PubMed ID: 28716248
[TBL] [Abstract][Full Text] [Related]
11. Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.
Albalawi IA; Mir R; Abu-Duhier FM
Endocr Metab Immune Disord Drug Targets; 2020; 20(5):760-770. PubMed ID: 31763970
[TBL] [Abstract][Full Text] [Related]
12.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
13. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
[TBL] [Abstract][Full Text] [Related]
14. Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B.
Hribal ML; Presta I; Procopio T; Marini MA; Stančáková A; Kuusisto J; Andreozzi F; Hammarstedt A; Jansson PA; Grarup N; Hansen T; Walker M; Stefan N; Fritsche A; Häring HU; Pedersen O; Smith U; Laakso M; Sesti G;
Diabetologia; 2011 Apr; 54(4):795-802. PubMed ID: 21234743
[TBL] [Abstract][Full Text] [Related]
15. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations.
Zhang H; Mao JS; Hu WF
Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116
[TBL] [Abstract][Full Text] [Related]
16. A common variant of CDKN2A (p16) predisposes to breast cancer.
Debniak T; Górski B; Huzarski T; Byrski T; Cybulski C; Mackiewicz A; Gozdecka-Grodecka S; Gronwald J; Kowalska E; Haus O; Grzybowska E; Stawicka M; Swiec M; Urbański K; Niepsuj S; Waśko B; Góźdź S; Wandzel P; Szczylik C; Surdyka D; Rozmiarek A; Zambrano O; Posmyk M; Narod SA; Lubinski J
J Med Genet; 2005 Oct; 42(10):763-5. PubMed ID: 15879498
[TBL] [Abstract][Full Text] [Related]
17. Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility.
Wang X; Li W; Ma L; Gao J; Liu J; Ping F; Nie M
Acta Diabetol; 2015 Oct; 52(5):951-8. PubMed ID: 25990668
[TBL] [Abstract][Full Text] [Related]
18. Association between type 2 diabetes and CDKN2A/B: a meta-analysis study.
Bao XY; Xie C; Yang MS
Mol Biol Rep; 2012 Feb; 39(2):1609-16. PubMed ID: 21625859
[TBL] [Abstract][Full Text] [Related]
19. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.
Campa D; Capurso G; Pastore M; Talar-Wojnarowska R; Milanetto AC; Landoni L; Maiello E; Lawlor RT; Malecka-Panas E; Funel N; Gazouli M; De Bonis A; Klüter H; Rinzivillo M; Delle Fave G; Hackert T; Landi S; Bugert P; Bambi F; Archibugi L; Scarpa A; Katzke V; Dervenis C; Liço V; Furlanello S; Strobel O; Tavano F; Basso D; Kaaks R; Pasquali C; Gentiluomo M; Rizzato C; Canzian F
Sci Rep; 2016 Dec; 6():39565. PubMed ID: 28008994
[TBL] [Abstract][Full Text] [Related]
20. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
